Literature DB >> 12048359

Hospital and outpatient health services utilization among HIV-infected patients in care in 1999.

.   

Abstract

BACKGROUND: The evolving epidemiology and therapeutic management of HIV disease has important implications for health care resource utilization in HIV-infected patients, and health care resource use data are also needed to support policy and financial decision making.
METHODS: Demographic, clinical, and resource utilization data were collected from 9 U.S. HIV primary and specialty care sites in calendar year 1999. Rates of resource use were calculated for hospital admission, length of hospital stay, and outpatient clinic/office visits.
RESULTS: The sample included 5255 patients from HIV primary care sites in 3 eastern, 3 midwestern, and 3 western areas of the United States. Hospital admissions accounted for an annual mean of 297 days per 100 persons/y in 1999. Hospital days ranged from a low of 165 per 100 persons/mo for a CD4 > 500 cells/mm(3) to 840 per 100 persons/mo for a CD4 < 50 cells/mm(3) (p <.01). Mean annual outpatient clinic/office visits were 10.7 per person in 1999. A declining CD4 level and an increasing HIV-1 RNA level were both associated with higher hospital and outpatient utilization. HAART use was associated with fewer hospital days, and a higher outpatient visit rate. Injecting drug use risk was associated with an increase in hospital days. African American race was associated with a higher number of hospital days, but a lower outpatient visit rate. Female gender was associated with higher outpatient utilization. Mean monthly inpatient and outpatient expenditures in 1999 were $423 and $168, respectively.
CONCLUSION: As HIV care continues to evolve, data from our network of HIV providers will be useful in quantifying changes in HIV health services utilization to guide policy makers, as well as HIV care payers and providers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048359     DOI: 10.1097/00126334-200205010-00003

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

Review 1.  The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors:  Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Economic models of antiretroviral therapy: searching for the optimal strategy.

Authors:  Fred J Hellinger
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Comparable sustained virologic suppression between community- and academic-based HIV care settings.

Authors:  Carolyn Chu; Moonseong Heo; Alex Peshansky; Galina Umanski; Paul Meissner; Cindy Voss; Peter A Selwyn
Journal:  J Am Board Fam Med       Date:  2015 Jan-Feb       Impact factor: 2.657

4.  Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008.

Authors:  Stephen A Berry; John A Fleishman; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-01       Impact factor: 3.731

5.  Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016.

Authors:  Thibaut Davy-Mendez; Sonia Napravnik; David A Wohl; Amy L Durr; Oksana Zakharova; Claire E Farel; Joseph J Eron
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

6.  Impact of hepatitis coinfection on hospitalization rates and causes in a multicenter cohort of persons living with HIV.

Authors:  Trevor A Crowell; Kelly A Gebo; Ashwin Balagopal; John A Fleishman; Allison L Agwu; Stephen A Berry
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

7.  Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.

Authors:  Charles F Haines; John A Fleishman; Baligh R Yehia; Bryan Lau; Stephen A Berry; Allison L Agwu; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

8.  Assessment of a medical outreach program to improve access to HIV care among marginalized individuals.

Authors:  Chinazo O Cunningham; John Paul Sanchez; Daliah I Heller; Nancy L Sohler
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

9.  Thirty-day hospital readmission rate among adults living with HIV.

Authors:  Stephen A Berry; John A Fleishman; Baligh R Yehia; P Todd Korthuis; Allison L Agwu; Richard D Moore; Kelly A Gebo
Journal:  AIDS       Date:  2013-08-24       Impact factor: 4.177

10.  Inpatient health services utilization among HIV-infected adult patients in care 2002-2007.

Authors:  Baligh R Yehia; John A Fleishman; Perrin L Hicks; Michelande Ridore; Richard D Moore; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.